CG Oncology CGON
NASDAQ CGON
$74.42 +0.09 (+0.12%)
As of: Sep 4, 2026 · 2:29 PM EDT

CG Oncology (CGON) Invested Capital (2024 - 2026)

Analysis

CG Oncology (CGON) Invested Capital (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.40 Bn 27.56 Bn - 19.13 Bn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 1.30 Bn
10 CG Oncology 6.56 Bn 6.56 Bn -2.77 Mn 1.03 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Bn
Mar 31, 2026 1.09 Bn
Dec 31, 2025 755.60 Mn
Sep 30, 2025 690.64 Mn
Dec 31, 2024 733.38 Mn